nodes	percent_of_prediction	percent_of_DWPC	metapath
Aripiprazole—CHRM2—type 1 diabetes mellitus	0.36	0.54	CbGaD
Aripiprazole—ADRB1—type 1 diabetes mellitus	0.307	0.46	CbGaD
Aripiprazole—Psychomotor skills impaired—Ramipril—type 1 diabetes mellitus	0.0116	0.0964	CcSEcCtD
Aripiprazole—HTR7—umbilical artery—type 1 diabetes mellitus	0.0109	0.183	CbGeAlD
Aripiprazole—Ischaemic stroke—Ramipril—type 1 diabetes mellitus	0.00838	0.0697	CcSEcCtD
Aripiprazole—Pemphigus—Ramipril—type 1 diabetes mellitus	0.00504	0.0419	CcSEcCtD
Aripiprazole—HTR2A—arteriole—type 1 diabetes mellitus	0.00391	0.0655	CbGeAlD
Aripiprazole—Blood potassium increased—Ramipril—type 1 diabetes mellitus	0.0032	0.0266	CcSEcCtD
Aripiprazole—Lower respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.00283	0.0235	CcSEcCtD
Aripiprazole—HTR7—autonomic nervous system—type 1 diabetes mellitus	0.00269	0.045	CbGeAlD
Aripiprazole—DRD1—nerve—type 1 diabetes mellitus	0.00242	0.0405	CbGeAlD
Aripiprazole—HTR3A—nerve—type 1 diabetes mellitus	0.00234	0.0391	CbGeAlD
Aripiprazole—Depressed mood—Ramipril—type 1 diabetes mellitus	0.00216	0.018	CcSEcCtD
Aripiprazole—Cerebral ischaemia—Ramipril—type 1 diabetes mellitus	0.002	0.0166	CcSEcCtD
Aripiprazole—White blood cell count decreased—Ramipril—type 1 diabetes mellitus	0.00194	0.0161	CcSEcCtD
Aripiprazole—HTR7—peripheral nervous system—type 1 diabetes mellitus	0.00194	0.0324	CbGeAlD
Aripiprazole—Transient ischaemic attack—Ramipril—type 1 diabetes mellitus	0.00191	0.0159	CcSEcCtD
Aripiprazole—Balance disorder—Ramipril—type 1 diabetes mellitus	0.00177	0.0147	CcSEcCtD
Aripiprazole—HTR2A—autonomic nervous system—type 1 diabetes mellitus	0.00168	0.028	CbGeAlD
Aripiprazole—Psoriasis—Ramipril—type 1 diabetes mellitus	0.00154	0.0128	CcSEcCtD
Aripiprazole—HTR7—nerve—type 1 diabetes mellitus	0.00151	0.0253	CbGeAlD
Aripiprazole—Parosmia—Ramipril—type 1 diabetes mellitus	0.00149	0.0124	CcSEcCtD
Aripiprazole—DRD2—nerve—type 1 diabetes mellitus	0.00143	0.0239	CbGeAlD
Aripiprazole—ADRA2A—peripheral nervous system—type 1 diabetes mellitus	0.00142	0.0238	CbGeAlD
Aripiprazole—Neuralgia—Ramipril—type 1 diabetes mellitus	0.00139	0.0116	CcSEcCtD
Aripiprazole—Burning sensation—Ramipril—type 1 diabetes mellitus	0.00139	0.0116	CcSEcCtD
Aripiprazole—Laryngospasm—Ramipril—type 1 diabetes mellitus	0.00129	0.0108	CcSEcCtD
Aripiprazole—HTR2A—peripheral nervous system—type 1 diabetes mellitus	0.00121	0.0202	CbGeAlD
Aripiprazole—Myocardial ischaemia—Ramipril—type 1 diabetes mellitus	0.0012	0.01	CcSEcCtD
Aripiprazole—H1F0—islet of Langerhans—type 1 diabetes mellitus	0.00119	0.0199	CbGeAlD
Aripiprazole—Endocrine disorder—Ramipril—type 1 diabetes mellitus	0.00117	0.00969	CcSEcCtD
Aripiprazole—HTR3A—islet of Langerhans—type 1 diabetes mellitus	0.00113	0.0189	CbGeAlD
Aripiprazole—Disturbance in attention—Ramipril—type 1 diabetes mellitus	0.00112	0.00927	CcSEcCtD
Aripiprazole—Proteinuria—Ramipril—type 1 diabetes mellitus	0.0011	0.00914	CcSEcCtD
Aripiprazole—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.0011	0.0183	CbGeAlD
Aripiprazole—Protein urine present—Ramipril—type 1 diabetes mellitus	0.00108	0.00902	CcSEcCtD
Aripiprazole—Glossitis—Ramipril—type 1 diabetes mellitus	0.00105	0.00872	CcSEcCtD
Aripiprazole—Leukocytosis—Ramipril—type 1 diabetes mellitus	0.00103	0.00855	CcSEcCtD
Aripiprazole—Creatinine increased—Ramipril—type 1 diabetes mellitus	0.00101	0.00844	CcSEcCtD
Aripiprazole—Hearing impaired—Ramipril—type 1 diabetes mellitus	0.00101	0.00844	CcSEcCtD
Aripiprazole—H1F0—retina—type 1 diabetes mellitus	0.00101	0.017	CbGeAlD
Aripiprazole—H1F0—nephron tubule—type 1 diabetes mellitus	0.000955	0.016	CbGeAlD
Aripiprazole—HTR2A—nerve—type 1 diabetes mellitus	0.000942	0.0158	CbGeAlD
Aripiprazole—Salivary hypersecretion—Ramipril—type 1 diabetes mellitus	0.000938	0.0078	CcSEcCtD
Aripiprazole—DRD5—lymphoid tissue—type 1 diabetes mellitus	0.000932	0.0156	CbGeAlD
Aripiprazole—Blood urea increased—Ramipril—type 1 diabetes mellitus	0.000912	0.00759	CcSEcCtD
Aripiprazole—Neuropathy—Ramipril—type 1 diabetes mellitus	0.000907	0.00754	CcSEcCtD
Aripiprazole—Ziprasidone—CHRM2—type 1 diabetes mellitus	0.000891	0.589	CrCbGaD
Aripiprazole—ADRA1B—kidney—type 1 diabetes mellitus	0.000889	0.0149	CbGeAlD
Aripiprazole—Rash maculo-papular—Ramipril—type 1 diabetes mellitus	0.000878	0.0073	CcSEcCtD
Aripiprazole—Urine output increased—Ramipril—type 1 diabetes mellitus	0.000873	0.00726	CcSEcCtD
Aripiprazole—Lightheadedness—Ramipril—type 1 diabetes mellitus	0.000864	0.00719	CcSEcCtD
Aripiprazole—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.000864	0.00719	CcSEcCtD
Aripiprazole—H1F0—cardiovascular system—type 1 diabetes mellitus	0.000858	0.0144	CbGeAlD
Aripiprazole—H1F0—kidney—type 1 diabetes mellitus	0.00084	0.0141	CbGeAlD
Aripiprazole—H1F0—pancreas—type 1 diabetes mellitus	0.000834	0.014	CbGeAlD
Aripiprazole—Sleep disorder—Ramipril—type 1 diabetes mellitus	0.00081	0.00674	CcSEcCtD
Aripiprazole—Polyuria—Ramipril—type 1 diabetes mellitus	0.000799	0.00664	CcSEcCtD
Aripiprazole—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.000799	0.00664	CcSEcCtD
Aripiprazole—Gastroenteritis—Ramipril—type 1 diabetes mellitus	0.000791	0.00658	CcSEcCtD
Aripiprazole—Deafness—Ramipril—type 1 diabetes mellitus	0.000784	0.00652	CcSEcCtD
Aripiprazole—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00078	0.00649	CcSEcCtD
Aripiprazole—Nasal congestion—Ramipril—type 1 diabetes mellitus	0.00077	0.0064	CcSEcCtD
Aripiprazole—Libido decreased—Ramipril—type 1 diabetes mellitus	0.000756	0.00629	CcSEcCtD
Aripiprazole—Amnesia—Ramipril—type 1 diabetes mellitus	0.000746	0.00621	CcSEcCtD
Aripiprazole—Dermatitis exfoliative—Ramipril—type 1 diabetes mellitus	0.000743	0.00618	CcSEcCtD
Aripiprazole—Atrial fibrillation—Ramipril—type 1 diabetes mellitus	0.00074	0.00615	CcSEcCtD
Aripiprazole—Purpura—Ramipril—type 1 diabetes mellitus	0.000728	0.00605	CcSEcCtD
Aripiprazole—Arthritis—Ramipril—type 1 diabetes mellitus	0.000722	0.006	CcSEcCtD
Aripiprazole—H1F0—lymphoid tissue—type 1 diabetes mellitus	0.000721	0.0121	CbGeAlD
Aripiprazole—Cardiac failure—Ramipril—type 1 diabetes mellitus	0.000719	0.00598	CcSEcCtD
Aripiprazole—Hypoglycaemia—Ramipril—type 1 diabetes mellitus	0.000719	0.00598	CcSEcCtD
Aripiprazole—Cerebrovascular accident—Ramipril—type 1 diabetes mellitus	0.000716	0.00595	CcSEcCtD
Aripiprazole—Hyponatraemia—Ramipril—type 1 diabetes mellitus	0.000704	0.00586	CcSEcCtD
Aripiprazole—Disturbance in sexual arousal—Ramipril—type 1 diabetes mellitus	0.000696	0.00579	CcSEcCtD
Aripiprazole—HTR1B—cardiovascular system—type 1 diabetes mellitus	0.000687	0.0115	CbGeAlD
Aripiprazole—CHRM2—cardiovascular system—type 1 diabetes mellitus	0.000683	0.0114	CbGeAlD
Aripiprazole—KCNH2—islet of Langerhans—type 1 diabetes mellitus	0.000682	0.0114	CbGeAlD
Aripiprazole—HTR1D—cardiovascular system—type 1 diabetes mellitus	0.000665	0.0111	CbGeAlD
Aripiprazole—Blood creatinine increased—Ramipril—type 1 diabetes mellitus	0.000657	0.00546	CcSEcCtD
Aripiprazole—HTR1D—kidney—type 1 diabetes mellitus	0.00065	0.0109	CbGeAlD
Aripiprazole—Liver function test abnormal—Ramipril—type 1 diabetes mellitus	0.000647	0.00538	CcSEcCtD
Aripiprazole—ADRB1—cardiovascular system—type 1 diabetes mellitus	0.000646	0.0108	CbGeAlD
Aripiprazole—Abdominal pain upper—Ramipril—type 1 diabetes mellitus	0.000641	0.00533	CcSEcCtD
Aripiprazole—Orthostatic hypotension—Ramipril—type 1 diabetes mellitus	0.000641	0.00533	CcSEcCtD
Aripiprazole—Breast disorder—Ramipril—type 1 diabetes mellitus	0.000634	0.00527	CcSEcCtD
Aripiprazole—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.000632	0.00525	CcSEcCtD
Aripiprazole—CHRM1—cardiovascular system—type 1 diabetes mellitus	0.000622	0.0104	CbGeAlD
Aripiprazole—Gastritis—Ramipril—type 1 diabetes mellitus	0.000621	0.00516	CcSEcCtD
Aripiprazole—Prochlorperazine—CHRM2—type 1 diabetes mellitus	0.00062	0.41	CrCbGaD
Aripiprazole—HTR2B—cardiovascular system—type 1 diabetes mellitus	0.000618	0.0103	CbGeAlD
Aripiprazole—Dysphagia—Ramipril—type 1 diabetes mellitus	0.000606	0.00504	CcSEcCtD
Aripiprazole—Asthma—Ramipril—type 1 diabetes mellitus	0.000606	0.00504	CcSEcCtD
Aripiprazole—Influenza—Ramipril—type 1 diabetes mellitus	0.000606	0.00504	CcSEcCtD
Aripiprazole—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.0006	0.00499	CcSEcCtD
Aripiprazole—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.000594	0.00494	CcSEcCtD
Aripiprazole—DRD2—retina—type 1 diabetes mellitus	0.000592	0.0099	CbGeAlD
Aripiprazole—Angina pectoris—Ramipril—type 1 diabetes mellitus	0.00059	0.00491	CcSEcCtD
Aripiprazole—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.000581	0.00483	CcSEcCtD
Aripiprazole—Neutropenia—Ramipril—type 1 diabetes mellitus	0.000567	0.00471	CcSEcCtD
Aripiprazole—Upper respiratory tract infection—Ramipril—type 1 diabetes mellitus	0.000563	0.00469	CcSEcCtD
Aripiprazole—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.000563	0.00943	CbGeAlD
Aripiprazole—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.000558	0.00464	CcSEcCtD
Aripiprazole—HTR1A—cardiovascular system—type 1 diabetes mellitus	0.000554	0.00927	CbGeAlD
Aripiprazole—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.000553	0.0046	CcSEcCtD
Aripiprazole—Weight increased—Ramipril—type 1 diabetes mellitus	0.000552	0.00459	CcSEcCtD
Aripiprazole—CHRM3—kidney—type 1 diabetes mellitus	0.000544	0.00911	CbGeAlD
Aripiprazole—ADRA2C—nephron tubule—type 1 diabetes mellitus	0.000542	0.00907	CbGeAlD
Aripiprazole—ADRA2A—islet of Langerhans—type 1 diabetes mellitus	0.000537	0.00899	CbGeAlD
Aripiprazole—Acute coronary syndrome—Ramipril—type 1 diabetes mellitus	0.000533	0.00443	CcSEcCtD
Aripiprazole—Renal failure—Ramipril—type 1 diabetes mellitus	0.000531	0.00442	CcSEcCtD
Aripiprazole—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00053	0.00441	CcSEcCtD
Aripiprazole—Myocardial infarction—Ramipril—type 1 diabetes mellitus	0.00053	0.00441	CcSEcCtD
Aripiprazole—HTR7—cardiovascular system—type 1 diabetes mellitus	0.000529	0.00886	CbGeAlD
Aripiprazole—Stomatitis—Ramipril—type 1 diabetes mellitus	0.000527	0.00438	CcSEcCtD
Aripiprazole—Jaundice—Ramipril—type 1 diabetes mellitus	0.000527	0.00438	CcSEcCtD
Aripiprazole—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.000525	0.00437	CcSEcCtD
Aripiprazole—Conjunctivitis—Ramipril—type 1 diabetes mellitus	0.000525	0.00437	CcSEcCtD
Aripiprazole—Sweating—Ramipril—type 1 diabetes mellitus	0.000518	0.00431	CcSEcCtD
Aripiprazole—HTR7—kidney—type 1 diabetes mellitus	0.000518	0.00867	CbGeAlD
Aripiprazole—Hepatobiliary disease—Ramipril—type 1 diabetes mellitus	0.000511	0.00425	CcSEcCtD
Aripiprazole—ADRA1A—cardiovascular system—type 1 diabetes mellitus	0.000511	0.00855	CbGeAlD
Aripiprazole—Epistaxis—Ramipril—type 1 diabetes mellitus	0.00051	0.00424	CcSEcCtD
Aripiprazole—Sinusitis—Ramipril—type 1 diabetes mellitus	0.000507	0.00422	CcSEcCtD
Aripiprazole—Agranulocytosis—Ramipril—type 1 diabetes mellitus	0.000504	0.00419	CcSEcCtD
Aripiprazole—KCNH2—cardiovascular system—type 1 diabetes mellitus	0.000493	0.00826	CbGeAlD
Aripiprazole—Hepatitis—Ramipril—type 1 diabetes mellitus	0.000485	0.00403	CcSEcCtD
Aripiprazole—Oedema peripheral—Ramipril—type 1 diabetes mellitus	0.000478	0.00397	CcSEcCtD
Aripiprazole—Connective tissue disorder—Ramipril—type 1 diabetes mellitus	0.000477	0.00397	CcSEcCtD
Aripiprazole—ADRA2C—kidney—type 1 diabetes mellitus	0.000476	0.00797	CbGeAlD
Aripiprazole—ADRA2C—pancreas—type 1 diabetes mellitus	0.000473	0.00792	CbGeAlD
Aripiprazole—Visual impairment—Ramipril—type 1 diabetes mellitus	0.000468	0.00389	CcSEcCtD
Aripiprazole—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.000453	0.00759	CbGeAlD
Aripiprazole—Tinnitus—Ramipril—type 1 diabetes mellitus	0.000452	0.00376	CcSEcCtD
Aripiprazole—Flushing—Ramipril—type 1 diabetes mellitus	0.00045	0.00374	CcSEcCtD
Aripiprazole—Immune system disorder—Ramipril—type 1 diabetes mellitus	0.000438	0.00364	CcSEcCtD
Aripiprazole—Mediastinal disorder—Ramipril—type 1 diabetes mellitus	0.000437	0.00364	CcSEcCtD
Aripiprazole—ADRA1A—lymphoid tissue—type 1 diabetes mellitus	0.000429	0.00718	CbGeAlD
Aripiprazole—Alopecia—Ramipril—type 1 diabetes mellitus	0.000429	0.00357	CcSEcCtD
Aripiprazole—Mental disorder—Ramipril—type 1 diabetes mellitus	0.000425	0.00353	CcSEcCtD
Aripiprazole—Malnutrition—Ramipril—type 1 diabetes mellitus	0.000422	0.00351	CcSEcCtD
Aripiprazole—Erythema—Ramipril—type 1 diabetes mellitus	0.000422	0.00351	CcSEcCtD
Aripiprazole—Tension—Ramipril—type 1 diabetes mellitus	0.000414	0.00345	CcSEcCtD
Aripiprazole—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.000414	0.00344	CcSEcCtD
Aripiprazole—Nervousness—Ramipril—type 1 diabetes mellitus	0.00041	0.00341	CcSEcCtD
Aripiprazole—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.000406	0.00338	CcSEcCtD
Aripiprazole—CYP3A5—kidney—type 1 diabetes mellitus	0.000399	0.00667	CbGeAlD
Aripiprazole—CYP3A5—pancreas—type 1 diabetes mellitus	0.000396	0.00663	CbGeAlD
Aripiprazole—Tremor—Ramipril—type 1 diabetes mellitus	0.000396	0.00329	CcSEcCtD
Aripiprazole—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.000392	0.00326	CcSEcCtD
Aripiprazole—HTR2A—retina—type 1 diabetes mellitus	0.00039	0.00653	CbGeAlD
Aripiprazole—Agitation—Ramipril—type 1 diabetes mellitus	0.000388	0.00323	CcSEcCtD
Aripiprazole—Angioedema—Ramipril—type 1 diabetes mellitus	0.000386	0.00321	CcSEcCtD
Aripiprazole—Malaise—Ramipril—type 1 diabetes mellitus	0.000381	0.00317	CcSEcCtD
Aripiprazole—Vertigo—Ramipril—type 1 diabetes mellitus	0.000379	0.00316	CcSEcCtD
Aripiprazole—Syncope—Ramipril—type 1 diabetes mellitus	0.000379	0.00315	CcSEcCtD
Aripiprazole—Leukopenia—Ramipril—type 1 diabetes mellitus	0.000378	0.00314	CcSEcCtD
Aripiprazole—ADRA2A—pancreas—type 1 diabetes mellitus	0.000377	0.00632	CbGeAlD
Aripiprazole—Palpitations—Ramipril—type 1 diabetes mellitus	0.000373	0.0031	CcSEcCtD
Aripiprazole—Loss of consciousness—Ramipril—type 1 diabetes mellitus	0.000371	0.00309	CcSEcCtD
Aripiprazole—Cough—Ramipril—type 1 diabetes mellitus	0.000369	0.00307	CcSEcCtD
Aripiprazole—Convulsion—Ramipril—type 1 diabetes mellitus	0.000366	0.00304	CcSEcCtD
Aripiprazole—Chest pain—Ramipril—type 1 diabetes mellitus	0.00036	0.00299	CcSEcCtD
Aripiprazole—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00036	0.00299	CcSEcCtD
Aripiprazole—Myalgia—Ramipril—type 1 diabetes mellitus	0.00036	0.00299	CcSEcCtD
Aripiprazole—Anxiety—Ramipril—type 1 diabetes mellitus	0.000358	0.00298	CcSEcCtD
Aripiprazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 1 diabetes mellitus	0.000357	0.00297	CcSEcCtD
Aripiprazole—Discomfort—Ramipril—type 1 diabetes mellitus	0.000355	0.00295	CcSEcCtD
Aripiprazole—Dry mouth—Ramipril—type 1 diabetes mellitus	0.000352	0.00292	CcSEcCtD
Aripiprazole—Confusional state—Ramipril—type 1 diabetes mellitus	0.000348	0.00289	CcSEcCtD
Aripiprazole—Oedema—Ramipril—type 1 diabetes mellitus	0.000345	0.00287	CcSEcCtD
Aripiprazole—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.000345	0.00287	CcSEcCtD
Aripiprazole—Shock—Ramipril—type 1 diabetes mellitus	0.000339	0.00282	CcSEcCtD
Aripiprazole—Nervous system disorder—Ramipril—type 1 diabetes mellitus	0.000338	0.00281	CcSEcCtD
Aripiprazole—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.000337	0.00281	CcSEcCtD
Aripiprazole—Tachycardia—Ramipril—type 1 diabetes mellitus	0.000336	0.0028	CcSEcCtD
Aripiprazole—Skin disorder—Ramipril—type 1 diabetes mellitus	0.000335	0.00278	CcSEcCtD
Aripiprazole—Hyperhidrosis—Ramipril—type 1 diabetes mellitus	0.000333	0.00277	CcSEcCtD
Aripiprazole—HTR2A—cardiovascular system—type 1 diabetes mellitus	0.00033	0.00553	CbGeAlD
Aripiprazole—Anorexia—Ramipril—type 1 diabetes mellitus	0.000329	0.00273	CcSEcCtD
Aripiprazole—HTR2A—kidney—type 1 diabetes mellitus	0.000323	0.00541	CbGeAlD
Aripiprazole—Hypotension—Ramipril—type 1 diabetes mellitus	0.000322	0.00268	CcSEcCtD
Aripiprazole—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.000314	0.00261	CcSEcCtD
Aripiprazole—Insomnia—Ramipril—type 1 diabetes mellitus	0.000312	0.00259	CcSEcCtD
Aripiprazole—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00031	0.00257	CcSEcCtD
Aripiprazole—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.000307	0.00256	CcSEcCtD
Aripiprazole—Somnolence—Ramipril—type 1 diabetes mellitus	0.000306	0.00255	CcSEcCtD
Aripiprazole—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.000303	0.00252	CcSEcCtD
Aripiprazole—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.0003	0.00249	CcSEcCtD
Aripiprazole—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.000299	0.00501	CbGeAlD
Aripiprazole—CYP3A4—kidney—type 1 diabetes mellitus	0.000299	0.00501	CbGeAlD
Aripiprazole—Gastrointestinal disorder—Ramipril—type 1 diabetes mellitus	0.000298	0.00247	CcSEcCtD
Aripiprazole—Fatigue—Ramipril—type 1 diabetes mellitus	0.000297	0.00247	CcSEcCtD
Aripiprazole—Constipation—Ramipril—type 1 diabetes mellitus	0.000295	0.00245	CcSEcCtD
Aripiprazole—CYP2D6—kidney—type 1 diabetes mellitus	0.000294	0.00493	CbGeAlD
Aripiprazole—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.000284	0.00236	CcSEcCtD
Aripiprazole—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.000282	0.00234	CcSEcCtD
Aripiprazole—Urticaria—Ramipril—type 1 diabetes mellitus	0.000274	0.00228	CcSEcCtD
Aripiprazole—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.000272	0.00227	CcSEcCtD
Aripiprazole—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.000272	0.00227	CcSEcCtD
Aripiprazole—ABCB1—retina—type 1 diabetes mellitus	0.000256	0.00428	CbGeAlD
Aripiprazole—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.000254	0.00211	CcSEcCtD
Aripiprazole—Asthenia—Ramipril—type 1 diabetes mellitus	0.000247	0.00206	CcSEcCtD
Aripiprazole—Pruritus—Ramipril—type 1 diabetes mellitus	0.000244	0.00203	CcSEcCtD
Aripiprazole—ABCB1—nephron tubule—type 1 diabetes mellitus	0.000241	0.00403	CbGeAlD
Aripiprazole—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.000236	0.00196	CcSEcCtD
Aripiprazole—Dizziness—Ramipril—type 1 diabetes mellitus	0.000228	0.0019	CcSEcCtD
Aripiprazole—Vomiting—Ramipril—type 1 diabetes mellitus	0.000219	0.00182	CcSEcCtD
Aripiprazole—Rash—Ramipril—type 1 diabetes mellitus	0.000217	0.00181	CcSEcCtD
Aripiprazole—Dermatitis—Ramipril—type 1 diabetes mellitus	0.000217	0.00181	CcSEcCtD
Aripiprazole—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.000216	0.00362	CbGeAlD
Aripiprazole—Headache—Ramipril—type 1 diabetes mellitus	0.000216	0.0018	CcSEcCtD
Aripiprazole—ABCB1—kidney—type 1 diabetes mellitus	0.000212	0.00354	CbGeAlD
Aripiprazole—ABCB1—pancreas—type 1 diabetes mellitus	0.00021	0.00352	CbGeAlD
Aripiprazole—Nausea—Ramipril—type 1 diabetes mellitus	0.000205	0.0017	CcSEcCtD
Aripiprazole—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.000182	0.00304	CbGeAlD
Aripiprazole—ADRB1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.62e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.62e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.61e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.61e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL2—type 1 diabetes mellitus	5.6e-06	3.72e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL2—type 1 diabetes mellitus	5.6e-06	3.71e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.59e-06	3.71e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—INS—type 1 diabetes mellitus	5.58e-06	3.7e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.58e-06	3.7e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.57e-06	3.69e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.57e-06	3.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.56e-06	3.69e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL2—type 1 diabetes mellitus	5.56e-06	3.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2RA—type 1 diabetes mellitus	5.56e-06	3.69e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—EGFR—type 1 diabetes mellitus	5.55e-06	3.68e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.55e-06	3.68e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.53e-06	3.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL2—type 1 diabetes mellitus	5.52e-06	3.66e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	5.46e-06	3.62e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.45e-06	3.62e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.45e-06	3.61e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	5.43e-06	3.6e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.42e-06	3.59e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—INS—type 1 diabetes mellitus	5.4e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.4e-06	3.58e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.37e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.37e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.37e-06	3.56e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL2—type 1 diabetes mellitus	5.36e-06	3.55e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.34e-06	3.54e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.33e-06	3.54e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—INS—type 1 diabetes mellitus	5.31e-06	3.52e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.3e-06	3.51e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL2—type 1 diabetes mellitus	5.29e-06	3.5e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.26e-06	3.49e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—INS—type 1 diabetes mellitus	5.25e-06	3.48e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—ALB—type 1 diabetes mellitus	5.24e-06	3.47e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.22e-06	3.46e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.21e-06	3.46e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.2e-06	3.45e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.19e-06	3.44e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—TYK2—type 1 diabetes mellitus	5.16e-06	3.42e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	5.15e-06	3.41e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IGF1—type 1 diabetes mellitus	5.14e-06	3.41e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.12e-06	3.4e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.12e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL2—type 1 diabetes mellitus	5.12e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—EGFR—type 1 diabetes mellitus	5.12e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	5.11e-06	3.39e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CD80—type 1 diabetes mellitus	5.1e-06	3.38e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.09e-06	3.38e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.09e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	5.08e-06	3.37e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CD80—type 1 diabetes mellitus	5.08e-06	3.36e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.07e-06	3.36e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—NOS3—type 1 diabetes mellitus	5.07e-06	3.36e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL2—type 1 diabetes mellitus	5.06e-06	3.36e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CD80—type 1 diabetes mellitus	5.06e-06	3.35e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling by GPCR—IL6—type 1 diabetes mellitus	5.04e-06	3.34e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Metabolism—NOS3—type 1 diabetes mellitus	5.01e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CD80—type 1 diabetes mellitus	5.01e-06	3.32e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CD80—type 1 diabetes mellitus	5e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	4.99e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.99e-06	3.31e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.96e-06	3.29e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—INS—type 1 diabetes mellitus	4.9e-06	3.25e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.89e-06	3.24e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.87e-06	3.23e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.83e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.82e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.82e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—HTR1E—Signaling Pathways—IL6—type 1 diabetes mellitus	4.82e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.82e-06	3.2e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—INS—type 1 diabetes mellitus	4.81e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—ALB—type 1 diabetes mellitus	4.81e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	4.81e-06	3.19e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.8e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—INS—type 1 diabetes mellitus	4.8e-06	3.18e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—INS—type 1 diabetes mellitus	4.78e-06	3.17e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.77e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL2—type 1 diabetes mellitus	4.76e-06	3.16e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.75e-06	3.15e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.74e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.74e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.74e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—INS—type 1 diabetes mellitus	4.73e-06	3.14e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—INS—type 1 diabetes mellitus	4.72e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.72e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.72e-06	3.13e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.71e-06	3.12e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.68e-06	3.1e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.66e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.66e-06	3.09e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.65e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CD80—type 1 diabetes mellitus	4.64e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.64e-06	3.08e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.64e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.63e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.62e-06	3.07e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.62e-06	3.06e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.6e-06	3.05e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Metabolism—NOS3—type 1 diabetes mellitus	4.6e-06	3.05e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.58e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.58e-06	3.04e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.57e-06	3.03e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.56e-06	3.02e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.54e-06	3.01e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.51e-06	2.99e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.45e-06	2.95e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	4.41e-06	2.92e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—INS—type 1 diabetes mellitus	4.39e-06	2.91e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.38e-06	2.9e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.34e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL2—type 1 diabetes mellitus	4.34e-06	2.88e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.32e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.31e-06	2.86e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.31e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.3e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.3e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL2—type 1 diabetes mellitus	4.3e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.3e-06	2.85e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.29e-06	2.84e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.28e-06	2.84e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.28e-06	2.84e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.28e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.27e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—DRD5—Signaling Pathways—IL6—type 1 diabetes mellitus	4.27e-06	2.83e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.26e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.25e-06	2.82e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IGF1—type 1 diabetes mellitus	4.24e-06	2.81e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.23e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.23e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—EGFR—type 1 diabetes mellitus	4.22e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.22e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—TYK2—type 1 diabetes mellitus	4.22e-06	2.8e-05	CbGpPWpGaD
Aripiprazole—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	4.22e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.21e-06	2.79e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.19e-06	2.78e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.17e-06	2.76e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.16e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.15e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL2—type 1 diabetes mellitus	4.15e-06	2.75e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—NOS3—type 1 diabetes mellitus	4.14e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.13e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.13e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.13e-06	2.74e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	4.11e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.1e-06	2.72e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.06e-06	2.69e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.04e-06	2.68e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—CASP3—type 1 diabetes mellitus	4.02e-06	2.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL2—type 1 diabetes mellitus	4.01e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.01e-06	2.66e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.99e-06	2.65e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.98e-06	2.64e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.96e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL2—type 1 diabetes mellitus	3.95e-06	2.62e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.93e-06	2.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—TYK2—type 1 diabetes mellitus	3.92e-06	2.6e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.91e-06	2.59e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.87e-06	2.57e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—NOS3—type 1 diabetes mellitus	3.85e-06	2.55e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.69e-06	2.45e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.65e-06	2.42e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.65e-06	2.42e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.64e-06	2.41e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.64e-06	2.41e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—INS—type 1 diabetes mellitus	3.63e-06	2.4e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.62e-06	2.4e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.62e-06	2.4e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.59e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.58e-06	2.38e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.58e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.58e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.57e-06	2.37e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.57e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL2—type 1 diabetes mellitus	3.56e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.56e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.56e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL2—type 1 diabetes mellitus	3.55e-06	2.36e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.55e-06	2.35e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.54e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.52e-06	2.34e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL2—type 1 diabetes mellitus	3.52e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.51e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.51e-06	2.33e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.5e-06	2.32e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.49e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.49e-06	2.31e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.47e-06	2.3e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	3.42e-06	2.27e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.38e-06	2.24e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	3.37e-06	2.23e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	3.33e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.32e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.32e-06	2.2e-05	CbGpPWpGaD
Aripiprazole—HTR6—Signaling Pathways—IL6—type 1 diabetes mellitus	3.29e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—HTR7—Signaling Pathways—IL6—type 1 diabetes mellitus	3.29e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.29e-06	2.18e-05	CbGpPWpGaD
Aripiprazole—HTR1D—Signaling Pathways—IL6—type 1 diabetes mellitus	3.27e-06	2.17e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—CASP3—type 1 diabetes mellitus	3.27e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL2—type 1 diabetes mellitus	3.26e-06	2.16e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling by GPCR—IL6—type 1 diabetes mellitus	3.24e-06	2.15e-05	CbGpPWpGaD
Aripiprazole—HTR1B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.2e-06	2.12e-05	CbGpPWpGaD
Aripiprazole—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	3.18e-06	2.11e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.17e-06	2.1e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.16e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—DRD4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.15e-06	2.09e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	3.13e-06	2.08e-05	CbGpPWpGaD
Aripiprazole—CHRM4—Signaling Pathways—IL6—type 1 diabetes mellitus	3.11e-06	2.06e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.07e-06	2.04e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.07e-06	2.03e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—EGFR—type 1 diabetes mellitus	3.02e-06	2e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.02e-06	2e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3.01e-06	2e-05	CbGpPWpGaD
Aripiprazole—HTR2B—Signaling Pathways—IL6—type 1 diabetes mellitus	3.01e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—STAT3—type 1 diabetes mellitus	3e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	3e-06	1.99e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.99e-06	1.98e-05	CbGpPWpGaD
Aripiprazole—CHRM5—Signaling Pathways—IL6—type 1 diabetes mellitus	2.98e-06	1.97e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.96e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.95e-06	1.96e-05	CbGpPWpGaD
Aripiprazole—DRD1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.84e-06	1.88e-05	CbGpPWpGaD
Aripiprazole—DRD3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.8e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.79e-06	1.85e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—STAT3—type 1 diabetes mellitus	2.74e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.74e-06	1.82e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.74e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.73e-06	1.81e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.72e-06	1.8e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.69e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.68e-06	1.78e-05	CbGpPWpGaD
Aripiprazole—ADRB1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.55e-06	1.69e-05	CbGpPWpGaD
Aripiprazole—ADRA2B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.53e-06	1.67e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—EGFR—type 1 diabetes mellitus	2.49e-06	1.65e-05	CbGpPWpGaD
Aripiprazole—HTR1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.44e-06	1.62e-05	CbGpPWpGaD
Aripiprazole—HTR2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.43e-06	1.61e-05	CbGpPWpGaD
Aripiprazole—ADRA2C—Signaling Pathways—IL6—type 1 diabetes mellitus	2.36e-06	1.56e-05	CbGpPWpGaD
Aripiprazole—ADRA1B—Signaling Pathways—IL6—type 1 diabetes mellitus	2.32e-06	1.54e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	2.23e-06	1.48e-05	CbGpPWpGaD
Aripiprazole—DRD2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.14e-06	1.42e-05	CbGpPWpGaD
Aripiprazole—HTR2A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.11e-06	1.4e-05	CbGpPWpGaD
Aripiprazole—HRH1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.1e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM1—Signaling Pathways—IL6—type 1 diabetes mellitus	2.1e-06	1.39e-05	CbGpPWpGaD
Aripiprazole—CHRM3—Signaling Pathways—IL6—type 1 diabetes mellitus	2.09e-06	1.38e-05	CbGpPWpGaD
Aripiprazole—CHRM2—Signaling Pathways—IL6—type 1 diabetes mellitus	2.07e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—ADRA1A—Signaling Pathways—IL6—type 1 diabetes mellitus	2.06e-06	1.37e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	2.05e-06	1.36e-05	CbGpPWpGaD
Aripiprazole—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.96e-06	1.3e-05	CbGpPWpGaD
Aripiprazole—ADRA2A—Signaling Pathways—IL6—type 1 diabetes mellitus	1.92e-06	1.27e-05	CbGpPWpGaD
